ATMPs revolution: empowering leaders of EU civic and patients’ advocacy groups

vita value and innovation of advanced therapies programme STD

#VITA – Value and InnovaTion of Advanced therapies

ATMPs revolution: empowering leaders of EU civic and patients’ advocacy groups

24 MAY 2022 | 15:00 – 17:00 CEST

EU online training seminar

If you missed the webinar you can find the recording link here

PROGRAM

Moderator: Maddalena D’Urso, Active Citizenship Network

15:00 – 15:10 Opening remarks

Mariano Votta - Director Active Citizenship Network/Cittadinanzattiva

15:10 – 15:50 ATMPs: a paradigm shift for patients, public decision-makers and healthcare systems

Andrea Grignolio - Senior Research Fellow - CNR Interdepartmental Center for Research Ethics and Integrity, Professor of History of Medicine - Vita-Salute San Raffaele University in Milan
Q&A

15:50 – 16:30 The ATMPs as an investment: addressing the public budget and sustainability issues

Americo Cicchetti - Professor of Healthcare Management at the Faculty of Economics, Università Cattolica del Sacro Cuore, Rome (Italy) and Director of the Advanced School of Health Economics and Management

Q&A

16:30 – 16:50 The PAGs perspective

Leire Solis - Health Policy and Advocacy Senior Manager at the International Patient Organisation for Primary Immunodeficiencies (IPOPI)
Q&A

16:50 Final remarks & next steps

 

About the speakers

pagina web seminario europeo VITA html 125d581c608a90c1
Andrea Grignolio
teaches History of Medicine and Bioethics at V.-S. San Raffaele University Milan and at Interdep. Center for Research Ethics and Integrity of National Research Council (CNR). He studied at the Centre Cavaillès of 'École Normale Supérieure of Paris, Research and Post-doctoral Fellow at Boston University, Visiting Scholar at UC Berkeley, and Research Fellow at the University François Rabelais of Tours.

He is author of papers appeared on international journals and of the books Vaccines: “Are They Worth a Shot?” (Springer 2018); together with Cattaneo E., De Falco J., “Ogni giorno. Tra scienza e politica”, 2016 (Everyday. Between science and politics); with Beccaria G., “Scienza&Democrazia”, 2014 (Science & Democracy).

At CNR he is member of Scientific Secretariat of the Research Ethics and Bioethics Committee, scientific director of the Vaccine Hesitancy Forum and of the Research Integrity Training Unit; in 2021 he has been the coordinator of the G-20 Italy Policy Paper on a Global Health Literacy Alliance.

pagina web seminario europeo VITA html 762f74e802d24963
Americo Cicchetti
is Professor of Healthcare Management at the Faculty of Economics, Università Cattolica del Sacro Cuore, Rome (Italy) and Director of the Advanced School of Health Economics and Management. He is the Director of Research of the Health Technoogy Assessment Unit of the A. Gemelli University Hospital in Rome. He has been associated partner of the European Network of Health Technology Assessment and Director of Health Technology Assessment International. Associate editor of Frontiers in Medical Technology – Regulatory Affairs and of the International Journal of Health Technology Assessment in Healthcare. Americo Cicchetti has actively participated ad co-PI to numerous EU research projects regarding HTA applications such as ADHopHTA (Adopting HTA in European Hospitals), IMPACT HTA, and others. He has been member of the Price and Reimbursement Committee of the Italian National Drug Agency (AIFA) from 2009 to 2015. He authored more that 150 papers and 10 books.

pagina web seminario europeo VITA html 6ee5d400ec986f2d
Leire Solís
is Senior Manager for Health Policy and Advocacy at the International Patient Organisation for Primary Immunodeficiencies (IPOPI) since 2014. In this capacity, she is involved in advocacy programmes at international, European and national level to ensure that the patient’s voice is heard. Additional responsibilities at IPOPI consist on monitoring the health policy environment affecting the PID community globally and support IPOPI’s national patient groups in their advocacy efforts. Leire is IPOPI’s alternate member to European Medicines Agency Patient and Consumer Working Party (PCWP), a member at the European Reference Network RITA Patient Organisation working group and at the Rare Disease International Advocacy Committee.

Prior to joining IPOPI, Leire worked for a European public affairs consultancy in Brussels and was in charge of planning and executing several policy campaigns for pharmaceutical companies, patient groups and scientific associations.
Leire holds a bachelor’s degree in Sociology, a Master’s in International Affairs and is a EUPATI Fellow on medicines research and development.

More information on the project here

Introductory documents:

· Add-ON tars #VITA

· Project ppt presentation (ITA)

· Rationale of the initiative

· An overall overview about ATMPs

· Technical Policy Report from the #VITA Working Group “THE ECONOMIC EVALUATION OF ADVANCED THERAPY MEDICINAL PRODUCTS: CHARACTERISTICS AND REASONS FOR A NEW ECONOMIC AND ACCOUNTING APPROACH” (ENITIT2).

With the non-conditioned sponsorship of #VITA – Value and Innovation for Advanced Therapies

For further information don't hesitate to contact Maddalena D'Urso: This email address is being protected from spambots. You need JavaScript enabled to view it.

Updated webpage in May 2022

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.